BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 25858513)

  • 1. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
    Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
    Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the sensitivity of the novel α4β2* nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys.
    Gallezot JD; Esterlis I; Bois F; Zheng MQ; Lin SF; Kloczynski T; Krystal JH; Huang Y; Sabri O; Carson RE; Cosgrove KP
    Synapse; 2014 Nov; 68(11):556-64. PubMed ID: 25043426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-[(18) F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical use.
    Hockley BG; Stewart MN; Sherman P; Quesada C; Kilbourn MR; Albin RL; Scott PJ
    J Labelled Comp Radiopharm; 2013 Oct; 56(12):595-9. PubMed ID: 24285235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.
    Hillmer AT; Esterlis I; Gallezot JD; Bois F; Zheng MQ; Nabulsi N; Lin SF; Papke RL; Huang Y; Sabri O; Carson RE; Cosgrove KP
    Neuroimage; 2016 Nov; 141():71-80. PubMed ID: 27426839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
    Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine-A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors.
    Ludwig FA; Smits R; Fischer S; Donat CK; Hoepping A; Brust P; Steinbach J
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27617996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
    Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
    J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel
    Li S; Cai Z; Zheng MQ; Holden D; Naganawa M; Lin SF; Ropchan J; Labaree D; Kapinos M; Lara-Jaime T; Navarro A; Huang Y
    J Nucl Med; 2018 Jan; 59(1):140-146. PubMed ID: 28747521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
    Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of (-)-[
    Bhatt S; Hillmer AT; Nabulsi N; Matuskey D; Lim K; Lin SF; Esterlis I; Carson RE; Huang Y; Cosgrove KP
    Synapse; 2018 Mar; 72(3):. PubMed ID: 29105121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norchloro-fluoro-homoepibatidine (NCFHEB) - a promising radioligand for neuroimaging nicotinic acetylcholine receptors with PET.
    Deuther-Conrad W; Patt JT; Lockman PR; Allen DD; Patt M; Schildan A; Ganapathy V; Steinbach J; Sabri O; Brust P
    Eur Neuropsychopharmacol; 2008 Mar; 18(3):222-9. PubMed ID: 17728108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics.
    Wong DF; Kuwabara H; Kim J; Brasic JR; Chamroonrat W; Gao Y; Valentine H; Willis W; Mathur A; McCaul ME; Wand G; Gean EG; Dannals RF; Horti AG
    J Nucl Med; 2013 Aug; 54(8):1308-14. PubMed ID: 23801676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization in nonhuman primates of (R)-[
    Zheng M; Ahmed H; Smart K; Xu Y; Holden D; Kapinos M; Felchner Z; Haider A; Tamagnan G; Carson RE; Huang Y; Ametamey SM
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2153-2162. PubMed ID: 35107627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosynthesis of racemic and enantiomerically pure (-)-[18F]flubatine--a promising PET radiotracer for neuroimaging of α4β2 nicotinic acetylcholine receptors.
    Fischer S; Hiller A; Smits R; Hoepping A; Funke U; Wenzel B; Cumming P; Sabri O; Steinbach J; Brust P
    Appl Radiat Isot; 2013 Apr; 74():128-36. PubMed ID: 23416407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+)-[
    Tiepolt S; Becker GA; Wilke S; Cecchin D; Rullmann M; Meyer PM; Barthel H; Hesse S; Patt M; Luthardt J; Wagenknecht G; Sattler B; Deuther-Conrad W; Ludwig FA; Fischer S; Gertz HJ; Smits R; Hoepping A; Steinbach J; Brust P; Sabri O
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):731-746. PubMed ID: 32935187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET Imaging Evaluation of Four σ
    Baum E; Cai Z; Bois F; Holden D; Lin SF; Lara-Jaime T; Kapinos M; Chen Y; Deuther-Conrad W; Fischer S; Dukic-Stefanovic S; Bunse P; Wünsch B; Brust P; Jia H; Huang Y
    J Nucl Med; 2017 Jun; 58(6):982-988. PubMed ID: 28232607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kinetics.
    Kuwabara H; Wong DF; Gao Y; Valentine H; Holt DP; Ravert HT; Dannals RF; Horti AG
    J Nucl Med; 2012 Jan; 53(1):121-9. PubMed ID: 22173841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo measurement of nicotinic acetylcholine receptors with [18F]norchloro-fluoro-homoepibatidine.
    Brust P; Patt JT; Deuther-Conrad W; Becker G; Patt M; Schildan A; Sorger D; Kendziorra K; Meyer P; Steinbach J; Sabri O
    Synapse; 2008 Mar; 62(3):205-18. PubMed ID: 18088060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.
    Le Foll B; Chefer SI; Kimes AS; Shumway D; Goldberg SR; Stein EA; Mukhin AG
    J Nucl Med; 2007 Sep; 48(9):1492-500. PubMed ID: 17704243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.